Neill S. Cooper25
Andrew Tracey20
Maya H Buch16
Peter T. Dawes12
Michelle Koo11
34Rafael Cáliz Cáliz
18Miguel A. Ferrer
18Sara Wedrén
14Ioanna Marinou
13Jens Thomas Vejlby Nielsen

Filter Results:

  • Full text PDF available (43)

Publication Year

1953
2018
  • This year (2)
  • Last 5 years (27)
  • Last 10 years (65)

Publication Type

Co-author

Journals and Conferences

Learn More
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles
The tumor necrosis factor (TNF) alpha gene lies within the class III region of the major histocompatibility complex (MHC), telomeric to the class II and centromeric to the class I region. We have… (More)
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in…
OBJECTIVE To determine whether rheumatoid factor (RF), anti-cyclic citrullinated peptide (CCP) antibodies, or carriage of shared epitope (SE) and PTPN22 genetic susceptibility variants predict… (More)
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis…
OBJECTIVE Assess ustekinumab efficacy (week 24/week 52) and safety (week 16/week 24/week 60) in patients with active psoriatic arthritis (PsA) despite treatment with conventional and/or biological… (More)